Functional cystic fibrosis transmembrane conductance regulator expression in cystic fibrosis airway epithelial cells by AAV6.2-mediated segmental trans-splicing. Academic Article uri icon

Overview

MeSH

  • Animals
  • Cell Line
  • Cystic Fibrosis
  • Genetic Vectors
  • Humans
  • RNA Precursors
  • RNA, Messenger
  • Rats

MeSH Major

  • Adenoviridae
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Epithelial Cells
  • Trans-Splicing

abstract

  • Cystic fibrosis is characterized by deficiency of the cystic fibrosis transmembrane conductance regulator (CFTR), a Cl(-) transporter. The packaging constraints of adeno-associated viral (AAV) vectors preclude delivery of both an active promoter and CFTR cDNA to target cells. We hypothesized that segmental trans-splicing, in which two AAV vectors deliver the 5' and 3' halves of the CFTR cDNA, could mediate splicing of two pre-mRNAs into a full-length, functional CFTR mRNA. Using a segmental trans-splicing 5' donor-3' acceptor pair that split the CFTR cDNA between exons 14a and 14b, cotransfection of donor and acceptor plasmids into CFTR(-) cells resulted in full-length CFTR message and protein. Microinjection of plasmids into CFTR(-) cells produced cAMP-activated Cl(-) conductance. Vectors created with an engineered human serotype, AAV6.2, were used to deliver CFTR donor and acceptor constructs, resulting in full-length CFTR mRNA and protein as well as cAMP-activated Cl(-) conductance in CFTR(-) cells, including human CF airway epithelial IB3-1 cells. Thus, segmental trans-splicing can be used with AAV vectors to mediate expression of CFTR, a strategy potentially applicable to individuals with CF.

publication date

  • March 2009

has subject area

  • Adenoviridae
  • Animals
  • Cell Line
  • Cystic Fibrosis
  • Cystic Fibrosis Transmembrane Conductance Regulator
  • Epithelial Cells
  • Genetic Vectors
  • Humans
  • RNA Precursors
  • RNA, Messenger
  • Rats
  • Trans-Splicing

Research

keywords

  • Journal Article

Identity

Language

  • eng

PubMed Central ID

  • PMC2855253

Digital Object Identifier (DOI)

  • 10.1089/hum.2008.173

PubMed ID

  • 19257851

Additional Document Info

start page

  • 267

end page

  • 281

volume

  • 20

number

  • 3